0.016260
0.000000
0.006669
0.000000
0.022075
0.000000
0.000000
0.000000
0.013910
0.00000
0.00000
0.00000
Robinson, R.C.
Heath, J.K.
Hawkins, N.
Samal, B.
Jones, E.Y.
Betzel, C.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
4
90.0
112.3
90.0
61.5
45.3
77.7
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
to be published
0353
Species Variation in Receptor Binding Site Revealed by the Medium Resolution X-ray Structure of Human Leukemia Inhibitory Factor
NE
FEBS Lett.
FEBLAL
0165
0014-5793
336
236
238
10.1016/0014-5793(93)80810-H
Crystallization and Preliminary X-ray Analysis of Leukemia Inhibitory Factor
1993
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
293
1
AREA DETECTOR
1993-01-15
MARRESEARCH
SINGLE WAVELENGTH
M
x-ray
1
0.9
1.0
DW32
LURE
0.9
SYNCHROTRON
LURE BEAMLINE DW32
17515.262
LEUKEMIA INHIBITORY FACTOR
1
man
polymer
LIF
no
no
LMNQIRSQLAQLNGSANALFILYYTAQGEPFPNNLEKLCGPNVTDFPPFHANGTEKAKLVELYRIVVYLGTSLGNITRDQ
KILNPSALSLHSKLNATADILRGLLSNVLCRLCSKYHVGHVDVTYGPDTSGKDVFQKKKLGCQLLGKYKQVISVLAQAF
LMNQIRSQLAQLNGSANALFILYYTAQGEPFPNNLEKLCGPNVTDFPPFHANGTEKAKLVELYRIVVYLGTSLGNITRDQ
KILNPSALSLHSKLNATADILRGLLSNVLCRLCSKYHVGHVDVTYGPDTSGKDVFQKKKLGCQLLGKYKQVISVLAQAF
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
9606
Homo sapiens
562
Escherichia coli
1
2.86
56.95
VAPOR DIFFUSION, SITTING DROP
6.0
200 mM sodium acetate, 100 mM cacodylate buffer, 30% w/v PEG 8000, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 289K
289
repository
Initial release
Version format compliance
Version format compliance
1
0
2001-03-21
1
1
2008-04-27
1
2
2011-07-13
RCSB
Y
RCSB
2000-03-17
REL
LEU
23
n
1
LEU
23
A
MET
24
n
2
MET
24
A
ASN
25
n
3
ASN
25
A
GLN
26
n
4
GLN
26
A
ILE
27
n
5
ILE
27
A
ARG
28
n
6
ARG
28
A
SER
29
n
7
SER
29
A
GLN
30
n
8
GLN
30
A
LEU
31
n
9
LEU
31
A
ALA
32
n
10
ALA
32
A
GLN
33
n
11
GLN
33
A
LEU
34
n
12
LEU
34
A
ASN
35
n
13
ASN
35
A
GLY
36
n
14
GLY
36
A
SER
37
n
15
SER
37
A
ALA
38
n
16
ALA
38
A
ASN
39
n
17
ASN
39
A
ALA
40
n
18
ALA
40
A
LEU
41
n
19
LEU
41
A
PHE
42
n
20
PHE
42
A
ILE
43
n
21
ILE
43
A
LEU
44
n
22
LEU
44
A
TYR
45
n
23
TYR
45
A
TYR
46
n
24
TYR
46
A
THR
47
n
25
THR
47
A
ALA
48
n
26
ALA
48
A
GLN
49
n
27
GLN
49
A
GLY
50
n
28
GLY
50
A
GLU
51
n
29
GLU
51
A
PRO
52
n
30
PRO
52
A
PHE
53
n
31
PHE
53
A
PRO
54
n
32
PRO
54
A
ASN
55
n
33
ASN
55
A
ASN
56
n
34
ASN
56
A
LEU
57
n
35
LEU
57
A
GLU
58
n
36
GLU
58
A
LYS
59
n
37
LYS
59
A
LEU
60
n
38
LEU
60
A
CYS
61
n
39
CYS
61
A
GLY
62
n
40
GLY
62
A
PRO
63
n
41
PRO
63
A
ASN
64
n
42
ASN
64
A
VAL
65
n
43
VAL
65
A
THR
66
n
44
THR
66
A
ASP
67
n
45
ASP
67
A
PHE
68
n
46
PHE
68
A
PRO
69
n
47
PRO
69
A
PRO
70
n
48
PRO
70
A
PHE
71
n
49
PHE
71
A
HIS
72
n
50
HIS
72
A
ALA
73
n
51
ALA
73
A
ASN
74
n
52
ASN
74
A
GLY
75
n
53
GLY
75
A
THR
76
n
54
THR
76
A
GLU
77
n
55
GLU
77
A
LYS
78
n
56
LYS
78
A
ALA
79
n
57
ALA
79
A
LYS
80
n
58
LYS
80
A
LEU
81
n
59
LEU
81
A
VAL
82
n
60
VAL
82
A
GLU
83
n
61
GLU
83
A
LEU
84
n
62
LEU
84
A
TYR
85
n
63
TYR
85
A
ARG
86
n
64
ARG
86
A
ILE
87
n
65
ILE
87
A
VAL
88
n
66
VAL
88
A
VAL
89
n
67
VAL
89
A
TYR
90
n
68
TYR
90
A
LEU
91
n
69
LEU
91
A
GLY
92
n
70
GLY
92
A
THR
93
n
71
THR
93
A
SER
94
n
72
SER
94
A
LEU
95
n
73
LEU
95
A
GLY
96
n
74
GLY
96
A
ASN
97
n
75
ASN
97
A
ILE
98
n
76
ILE
98
A
THR
99
n
77
THR
99
A
ARG
100
n
78
ARG
100
A
ASP
101
n
79
ASP
101
A
GLN
102
n
80
GLN
102
A
LYS
103
n
81
LYS
103
A
ILE
104
n
82
ILE
104
A
LEU
105
n
83
LEU
105
A
ASN
106
n
84
ASN
106
A
PRO
107
n
85
PRO
107
A
SER
108
n
86
SER
108
A
ALA
109
n
87
ALA
109
A
LEU
110
n
88
LEU
110
A
SER
111
n
89
SER
111
A
LEU
112
n
90
LEU
112
A
HIS
113
n
91
HIS
113
A
SER
114
n
92
SER
114
A
LYS
115
n
93
LYS
115
A
LEU
116
n
94
LEU
116
A
ASN
117
n
95
ASN
117
A
ALA
118
n
96
ALA
118
A
THR
119
n
97
THR
119
A
ALA
120
n
98
ALA
120
A
ASP
121
n
99
ASP
121
A
ILE
122
n
100
ILE
122
A
LEU
123
n
101
LEU
123
A
ARG
124
n
102
ARG
124
A
GLY
125
n
103
GLY
125
A
LEU
126
n
104
LEU
126
A
LEU
127
n
105
LEU
127
A
SER
128
n
106
SER
128
A
ASN
129
n
107
ASN
129
A
VAL
130
n
108
VAL
130
A
LEU
131
n
109
LEU
131
A
CYS
132
n
110
CYS
132
A
ARG
133
n
111
ARG
133
A
LEU
134
n
112
LEU
134
A
CYS
135
n
113
CYS
135
A
SER
136
n
114
SER
136
A
LYS
137
n
115
LYS
137
A
TYR
138
n
116
TYR
138
A
HIS
139
n
117
HIS
139
A
VAL
140
n
118
VAL
140
A
GLY
141
n
119
GLY
141
A
HIS
142
n
120
HIS
142
A
VAL
143
n
121
VAL
143
A
ASP
144
n
122
ASP
144
A
VAL
145
n
123
VAL
145
A
THR
146
n
124
THR
146
A
TYR
147
n
125
TYR
147
A
GLY
148
n
126
GLY
148
A
PRO
149
n
127
PRO
149
A
ASP
150
n
128
ASP
150
A
THR
151
n
129
THR
151
A
SER
152
n
130
SER
152
A
GLY
153
n
131
GLY
153
A
LYS
154
n
132
LYS
154
A
ASP
155
n
133
ASP
155
A
VAL
156
n
134
VAL
156
A
PHE
157
n
135
PHE
157
A
GLN
158
n
136
GLN
158
A
LYS
159
n
137
LYS
159
A
LYS
160
n
138
LYS
160
A
LYS
161
n
139
LYS
161
A
LEU
162
n
140
LEU
162
A
GLY
163
n
141
GLY
163
A
CYS
164
n
142
CYS
164
A
GLN
165
n
143
GLN
165
A
LEU
166
n
144
LEU
166
A
LEU
167
n
145
LEU
167
A
GLY
168
n
146
GLY
168
A
LYS
169
n
147
LYS
169
A
TYR
170
n
148
TYR
170
A
LYS
171
n
149
LYS
171
A
GLN
172
n
150
GLN
172
A
VAL
173
n
151
VAL
173
A
ILE
174
n
152
ILE
174
A
SER
175
n
153
SER
175
A
VAL
176
n
154
VAL
176
A
LEU
177
n
155
LEU
177
A
ALA
178
n
156
ALA
178
A
GLN
179
n
157
GLN
179
A
ALA
180
n
158
ALA
180
A
PHE
181
n
159
PHE
181
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
MET
24
13.94
1
A
ILE
27
10.37
1
A
ARG
28
-12.24
1
A
LEU
31
-10.54
1
A
GLN
33
11.17
1
A
LEU
34
11.30
1
A
GLY
36
-12.58
1
A
TYR
46
-10.11
1
A
GLN
49
-11.51
1
A
ASN
56
-14.30
1
A
LEU
57
11.07
1
A
ASP
67
12.50
1
A
PHE
71
-13.18
1
A
LEU
81
12.71
1
A
VAL
82
-13.62
1
A
LEU
84
10.43
1
A
TYR
85
-11.90
1
A
ILE
87
-14.15
1
A
VAL
89
-10.77
1
A
LEU
91
-13.43
1
A
SER
94
-12.03
1
A
LEU
95
11.63
1
A
ARG
100
-14.38
1
A
ASP
101
-11.11
1
A
ILE
104
-11.83
1
A
SER
111
-14.44
1
A
HIS
113
-10.84
1
A
ASN
117
14.30
1
A
THR
119
10.68
1
A
ALA
120
-10.33
1
A
ASP
121
14.73
1
A
ILE
122
-10.55
1
A
LEU
123
-10.06
1
A
LEU
126
11.25
1
A
LEU
127
-10.40
1
A
LYS
137
-10.34
1
A
TYR
138
12.26
1
A
HIS
142
10.16
1
A
ASP
144
-10.94
1
A
ASP
150
-12.24
1
A
ASP
155
11.14
1
A
LEU
162
13.53
1
A
CYS
164
-12.60
1
A
TYR
170
-12.88
1
A
LYS
171
-12.98
1
A
SER
175
12.28
1
A
VAL
176
-11.93
1
A
TYR
46
0.093
SIDE CHAIN
1
A
A
NE2
CD2
HIS
HIS
113
113
-0.071
0.011
1.373
1.302
N
1
A
A
NE2
CD2
HIS
HIS
139
139
-0.068
0.011
1.373
1.305
N
1
A
A
NE2
CD2
HIS
HIS
142
142
-0.072
0.011
1.373
1.301
N
1
A
A
CE1
CE1
HIS
HIS
142
142
1.84
1_555
2_655
1
A
ALA
32
-59.49
-72.38
1
A
PRO
63
-49.42
103.92
1
A
VAL
65
-43.03
105.02
1
A
THR
66
-44.31
-91.43
1
A
PRO
69
-33.66
123.57
1
A
GLU
77
-35.83
-39.93
1
A
ALA
109
-50.75
93.24
1
A
LEU
134
-84.35
-71.26
1
A
SER
136
-86.44
-156.87
1
A
LYS
137
-35.67
99.87
1
A
TYR
138
155.35
-39.49
1
A
HIS
139
73.06
86.36
1
A
VAL
145
-137.66
-36.72
1
A
THR
146
61.58
86.55
1
A
TYR
147
-43.27
155.00
1
A
ASP
150
-105.63
53.81
1
A
THR
151
-48.86
104.87
1
A
SER
152
-152.74
-32.60
0.293
0.191
3.5
20.0
2728
2728
1
0
0
3.5
20.0
0
1520
0
0
1520
0.004
1.25
3.5
1EMR
2728
0.035
1
99.4
data reduction
DENZO
data scaling
SCALEPACK
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
CRYSTAL STRUCTURE OF HUMAN LEUKEMIA INHIBITORY FACTOR (LIF)
CRYSTAL STRUCTURE OF HUMAN LEUKEMIA INHIBITORY FACTOR (LIF)
1
N
N
A
ASN
25
A
ASN
3
HELX_P
A
GLY
50
A
GLY
28
1
1
26
A
ASN
56
A
ASN
34
HELX_P
A
CYS
61
A
CYS
39
1
2
6
A
THR
76
A
THR
54
HELX_P
A
ASN
106
A
ASN
84
1
3
31
A
ALA
109
A
ALA
87
HELX_P
A
SER
136
A
SER
114
1
4
28
A
ASP
155
A
ASP
133
HELX_P
A
ALA
178
A
ALA
156
1
5
24
A
GLN
179
A
GLN
157
HELX_P
A
PHE
181
A
PHE
159
5
6
3
disulf
2.030
A
CYS
61
A
SG
CYS
39
1_555
A
CYS
164
A
SG
CYS
142
1_555
GENE REGULATION
4-helix bundle, GENE REGULATION
A
GLU
51
A
GLU
29
1
A
PRO
52
A
PRO
30
2.61
LIF_HUMAN
UNP
1
P15018
44
202
1EMR
23
181
P15018
A
1
1
159
1
ASP
CONFLICT
GLU
58
1EMR
A
P15018
UNP
79
36
1
ILE
CONFLICT
VAL
173
1EMR
A
P15018
UNP
194
151
1
ALA
CONFLICT
SER
175
1EMR
A
P15018
UNP
196
153
5
C 1 2 1